Rodman and Renshaw upgrades Prana Biotechnology (Nasdaq: PRAN) from Market Perform to Market Outperform. Price target $8.

This article: 93 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE